Related references
Note: Only part of the references are listed.CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment
Metka Novak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth
Geraldine Xue En Tu et al.
STEM CELL RESEARCH & THERAPY (2020)
Transforming Growth Factor-β Promotes Homing and Therapeutic Efficacy of Human Mesenchymal Stem Cells to Glioblastoma
Man Li et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma
Hye Rim Han et al.
ANTICANCER RESEARCH (2019)
Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton's Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity
S. Sharif et al.
STEM CELL REVIEWS AND REPORTS (2018)
Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton's Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity
S. Sharif et al.
STEM CELL REVIEWS AND REPORTS (2018)
Low-dose irradiated mesenchymal stromal cells break tumor defensive properties in vivo
Francesca Romana Stefani et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
Anne Clavreul et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Selective sensitiveness of mesenchymal stem cells to shock waves leads to anticancer effect in human cancer cell co-cultures
Federica Foglietta et al.
LIFE SCIENCES (2017)
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
Gila Kazimirsky et al.
STEM CELL RESEARCH & THERAPY (2016)
Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas
Sung Hugh Choi et al.
MOLECULAR THERAPY (2015)
Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy
Jordi Martinez-Quintanilla et al.
MOLECULAR THERAPY (2015)
Brain tumour cells interconnect to a functional and resistant network
Matthias Osswald et al.
NATURE (2015)
Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1
Kiran Kumar Velpula et al.
Oncotarget (2015)
Stem Cells Loaded With Multimechanistic Oncolytic Herpes Simplex Virus Variants for Brain Tumor Therapy
Matthias Duebgen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Conditioned Media from Human Adipose Tissue-Derived Mesenchymal Stem Cells and Umbilical Cord-Derived Mesenchymal Stem Cells Efficiently Induced the Apoptosis and Differentiation in Human Glioma Cell Lines In Vitro
Chao Yang et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Oncolytic Viruses and Their Application to Cancer Immunotherapy
E. Antonio Chiocca et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Stem cell-based therapy for malignant glioma
Daniel Bexell et al.
CANCER TREATMENT REVIEWS (2013)
MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells
Shang Liu et al.
FEBS LETTERS (2013)
Human adipose tissue-derived mesenchymal stem cells: Characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas
Seung Ah Choi et al.
EUROPEAN JOURNAL OF CANCER (2012)
Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy
Mathilde Roger et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Glioblastoma Therapy with Cytotoxic Mesenchymal Stromal Cells Optimized by Bioluminescence Imaging of Tumor and Therapeutic Cell Response
Maria Alieva et al.
PLOS ONE (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Human Mesenchymal Stem Cells and Their Use in Cell-Based Therapies
Helena Motaln et al.
CANCER (2010)
A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines
Anne Vessieres et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies
A. Stolzing et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2008)
Cytotoxicity of human umbilical cord blood-derived mesenchymal stem cells against human malignant glioma cells
Seok-Gu Kang et al.
CHILDS NERVOUS SYSTEM (2008)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells
Mateo Ziu et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
A Nakamizo et al.
CANCER RESEARCH (2005)
Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells
U Fischer et al.
ONCOGENE (2005)
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
K Nakamura et al.
GENE THERAPY (2004)
AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma:: A randomised, controlled study
A Immonen et al.
MOLECULAR THERAPY (2004)
Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells
S Mohanam et al.
ONCOGENE (2001)
The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells:: role in transendothelial/stromal migration and engraftment of NOD/SCID mice
A Peled et al.
BLOOD (2000)
Share Paper
